Armata Pharmaceuticals Insider Trades
NYSE: ARMPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Armata Pharmaceuticals insider activity
Over the last 12 months, Armata Pharmaceuticals insiders reported 3 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Birx Deborah (Chief Executive Officer) reporting a transaction in 14,041 shares at $4.26 on Jul 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ARMP's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ARMP insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 10, 2026 | Birx DeborahChief Executive Officer | Tax withholding | 14,041 | $59.81K | Form 4 |
| Mar 14, 2026 | Kyme PierreChief Business Officer | Tax withholding | 1,030 | $10.86K | Form 4 |
| Mar 14, 2026 | Birx DeborahChief Executive Officer | Tax withholding | 4,919 | $51.85K | Form 4 |
| Jul 10, 2025 | Birx DeborahChief Executive Officer | Tax withholding | 13,637 | $30.96K | Form 4 |
| Mar 14, 2025 | Kyme PierreChief Business Officer | Tax withholding | 1,027 | $2.00K | Form 4 |
| Mar 14, 2025 | Birx DeborahChief Executive Officer | Tax withholding | 6,061 | $11.82K | Form 4 |
| Jul 10, 2024 | Birx DeborahChief Executive Officer | Tax withholding | 22,925 | $61.44K | Form 4 |
| Mar 14, 2024 | Birx DeborahChief Executive Officer | Award | 60,000 | — | Form 4 |
| Mar 14, 2024 | Rychlik RichardCorporate Controller and PFO | Award | 10,000 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4